{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:26:15Z","timestamp":1772670375275,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"crossref","award":["R01AR074500-01A"],"award-info":[{"award-number":["R01AR074500-01A"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"crossref","award":["U01-AI119125"],"award-info":[{"award-number":["U01-AI119125"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11926-020-00958-9","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T20:02:25Z","timestamp":1600718545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMAN"],"prefix":"10.1007","volume":"22","author":[{"given":"Stacie","family":"Bell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph F.","family":"Merola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan E.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Ogdie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Ritchlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1072-6994","authenticated-orcid":false,"given":"Jose U.","family":"Scher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"958_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11926-019-0876-z","volume":"21","author":"C Ritchlin","year":"2019","unstructured":"Ritchlin C, Scher JU. Strategies to improve outcomes in psoriatic arthritis. Curr Rheumatol Rep. 2019;21:72. https:\/\/doi.org\/10.1007\/s11926-019-0876-z.","journal-title":"Curr Rheumatol Rep"},{"key":"958_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","volume":"15","author":"JU Scher","year":"2019","unstructured":"\u2022\u2022 Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15:153\u201366. https:\/\/doi.org\/10.1038\/s41584-019-0175-0This study provides a comprehensive description of risk factors for transition from psoriasis to psoriatic arthritis and discusses clinical, demograophic, and molecukar features that can predict this progression.","journal-title":"Nat Rev Rheumatol"},{"key":"958_CR3","unstructured":"NIAMS. Roundtable on Gaps and Emerging Opportunities in Psoriatic Arthritis. (2017). https:\/\/www.niams.nih.gov\/about\/meetingsevents\/roundtables\/forum-gaps-psoriatic"},{"key":"958_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3899\/jrheum.200123","volume":"96","author":"R Waxman","year":"2020","unstructured":"Waxman R, et al. Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting. J Rheumatol Suppl. 2020;96:25\u201330. https:\/\/doi.org\/10.3899\/jrheum.200123.","journal-title":"J Rheumatol Suppl"},{"issue":"155\u2013168","key":"958_CR5","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1177\/2475530319855519","volume":"4","author":"Abstracts From","year":"2019","unstructured":"Abstracts From. Cure symposium the future of psoriatic disease: prevention, precision medicine, and cure. Journal of Psoriasis and Psoriatic Arthritis. 2019;4(155\u2013168):2019\u2013168. https:\/\/doi.org\/10.1177\/2475530319855519.","journal-title":"Journal of Psoriasis and Psoriatic Arthritis"},{"key":"958_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/2475530320913879","volume":"5","author":"R Haberman","year":"2020","unstructured":"Haberman R, Perez-Chada LM, Siegel E, Reginato AM, Webster D, Chandran V, et al. Psoriasis and psoriatic arthritis clinics multicenter advancement network consortium (PPACMAN) 2018 annual meeting summary. Journal of Psoriasis and Psoriatic Arthritis. 2020;5:68\u201372. https:\/\/doi.org\/10.1177\/2475530320913879.","journal-title":"Journal of Psoriasis and Psoriatic Arthritis"},{"key":"958_CR7","unstructured":"National Psoriasis Foundation. https:\/\/www.psoriasis.org"},{"key":"958_CR8","unstructured":"Initiative, N. P. P. (2020). https:\/\/www.psoriasis.org\/psoriasis-prevention-initiative\/"},{"key":"958_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3899\/jrheum.170148","volume":"44","author":"JP Okhovat","year":"2017","unstructured":"Okhovat JP, Ogdie A, Reddy SM, Rosen CF, Scher JU, Merola JF. Psoriasis and psoriatic arthritis clinics multicenter advancement network consortium (PPACMAN) survey: benefits and challenges of combined rheumatology-dermatology clinics. J Rheumatol. 2017;44:693\u20134. https:\/\/doi.org\/10.3899\/jrheum.170148.","journal-title":"J Rheumatol"},{"key":"958_CR10","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1038\/npjparkd.2016.6","volume":"2","author":"AD Trister","year":"2016","unstructured":"Trister AD, Dorsey ER, Friend SH. Smartphones as new tools in the management and understanding of Parkinson\u2019s disease. NPJ Parkinsons Dis. 2016;2:16006. https:\/\/doi.org\/10.1038\/npjparkd.2016.6.","journal-title":"NPJ Parkinsons Dis"},{"key":"958_CR11","doi-asserted-by":"publisher","first-page":"160011","DOI":"10.1038\/sdata.2016.11","volume":"3","author":"BM Bot","year":"2016","unstructured":"Bot BM, Suver C, Neto EC, Kellen M, Klein A, Bare C, et al. The mPower study, Parkinson disease mobile data collected using ResearchKit. Sci Data. 2016;3:160011. https:\/\/doi.org\/10.1038\/sdata.2016.11.","journal-title":"Sci Data"},{"key":"958_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/cpt.1781","volume":"107","author":"L Omberg","year":"2020","unstructured":"Omberg L, Chaibub Neto E, Mangravite LM. Data science approaches for effective use of mobile device-based collection of real-world data. Clin Pharmacol Ther. 2020;107:719\u201321. https:\/\/doi.org\/10.1002\/cpt.1781.","journal-title":"Clin Pharmacol Ther"},{"key":"958_CR13","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.6521","volume":"5","author":"M Doerr","year":"2017","unstructured":"Doerr M, Maguire Truong A, Bot BM, Wilbanks J, Suver C, Mangravite LM. Formative evaluation of participant experience with mobile eConsent in the app-mediated Parkinson mPower study: a mixed methods study. JMIR Mhealth Uhealth. 2017;5:e14. https:\/\/doi.org\/10.2196\/mhealth.6521.","journal-title":"JMIR Mhealth Uhealth"},{"key":"958_CR14","doi-asserted-by":"publisher","first-page":"170005","DOI":"10.1038\/sdata.2017.5","volume":"4","author":"DE Webster","year":"2017","unstructured":"Webster DE, Suver C, Doerr M, Mounts E, Domenico L, Petrie T, et al. The Mole Mapper study, mobile phone skin imaging and melanoma risk data collected using ResearchKit. Sci Data. 2017;4:170005. https:\/\/doi.org\/10.1038\/sdata.2017.5.","journal-title":"Sci Data"},{"key":"958_CR15","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/art.39573","volume":"68","author":"LC Coates","year":"2016","unstructured":"Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, et al. Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 2016;68:1060\u201371. https:\/\/doi.org\/10.1002\/art.39573.","journal-title":"Arthritis Rheumatol"},{"key":"958_CR16","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665\u201373. https:\/\/doi.org\/10.1002\/art.21972.","journal-title":"Arthritis Rheum"},{"key":"958_CR17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/annrheumdis-2012-201341","volume":"72","author":"PS Helliwell","year":"2013","unstructured":"Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K, et al. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis. 2013;72:986\u201391. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201341.","journal-title":"Ann Rheum Dis"},{"key":"958_CR18","doi-asserted-by":"publisher","first-page":"e23-e23","DOI":"10.1136\/annrheumdis-2017-212004","volume":"77","author":"W Tillett","year":"2018","unstructured":"Tillett W, Orbai AM, Ogdie A, Leung YY, Strand V, Gladman DD, et al. GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies. Ann Rheum Dis. 2018;77:e23-e23. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212004.","journal-title":"Ann Rheum Dis"},{"key":"958_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","volume":"372","author":"FS Collins","year":"2015","unstructured":"Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793\u20135. https:\/\/doi.org\/10.1056\/NEJMp1500523.","journal-title":"N Engl J Med"},{"key":"958_CR20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/clpt.2011.321","volume":"91","author":"M Goldman","year":"2012","unstructured":"Goldman M. The innovative medicines initiative: a European response to the innovation challenge. Clin Pharmacol Ther. 2012;91:418\u201325. https:\/\/doi.org\/10.1038\/clpt.2011.321.","journal-title":"Clin Pharmacol Ther"},{"key":"958_CR21","doi-asserted-by":"publisher","unstructured":"\u2022 Dolgin E. Massive NIH-industry project opens portals to target validation. Nat Rev Drug Discov. 2019. https:\/\/doi.org\/10.1038\/d41573-019-00033-8This study provides a description of how public-private partnerships through NIH-led initiatives can accelerate the discovery of novel targes in inflammatory conditions.","DOI":"10.1038\/d41573-019-00033-8"},{"key":"958_CR22","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","volume":"20","author":"F Zhang","year":"2019","unstructured":"Zhang F, et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol. 2019;20:928\u201342. https:\/\/doi.org\/10.1038\/s41590-019-0378-1.","journal-title":"Nat Immunol"},{"key":"958_CR23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41467-018-02892-y","volume":"9","author":"F Mizoguchi","year":"2018","unstructured":"Mizoguchi F, Slowikowski K, Wei K, Marshall JL, Rao DA, Chang SK, et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat Commun. 2018;9:789. https:\/\/doi.org\/10.1038\/s41467-018-02892-y.","journal-title":"Nat Commun"},{"key":"958_CR24","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","volume":"20","author":"E Der","year":"2019","unstructured":"Der E, et al. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol. 2019;20:915\u201327. https:\/\/doi.org\/10.1038\/s41590-019-0386-1.","journal-title":"Nat Immunol"},{"key":"958_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/247553031700200307","volume":"2","author":"L Afifi","year":"2017","unstructured":"Afifi L, Shankle L, Armstrong AW, Boas M, Bridges A, Chiguil V, et al. National Psoriasis Foundation priorities for patient-centered research: proceedings from the 2016 conference. J Psoriasis Psoriatic Arthritis. 2017;2:73\u201380. https:\/\/doi.org\/10.1177\/247553031700200307.","journal-title":"J Psoriasis Psoriatic Arthritis"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00958-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-020-00958-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00958-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:20:01Z","timestamp":1632183601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-020-00958-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["958"],"URL":"https:\/\/doi.org\/10.1007\/s11926-020-00958-9","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"21 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"UCB, Janssen, Abbvie, Pfizer, Novartis, Sanofi, BMS (Scher); AbbVie, Amgen, BMS, Celgene, Janssen, Lilly, Novartis, Pfizer, Corrona (Ogdie); AbbVie, Lilly, Janssen, Novartis, BMS, Pfizer, Amgen, UCB (FitzGerald); Abbvie, Amgen, Janssen, Novartis, Pfizer, Regeneron, and TRex Bio (Liao)BMS, Abbvie, Dermavant, Lilly, Novartis, Janssen, UCB, Sun Pharma, Pfizer, EMD Sorono (Merola). Novartis, Janssen, Pfizer, Otsuka (Webster).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"As this is a review article, this article does not contain any studies with human or animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"78"}}